Clinical Trial Update: A Randomized Study of Sulindac in Oral Premalignant Lesions [NA]

View source ↗

Summary

A randomized trial assessing the effect of sulindac on oral premalignant lesions (leukoplakia). The study is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukoplakia Oral

Drugs mentioned

• Sulindac (sulindac)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukoplakia, Oral, Benign Neoplasms | NA | Status: COMPLETED | Results posted: 2020-11-19